China SXT Pharmaceuticals Ratios (2018-2025) | SXTC

Ratios Mar2018 Sep2018 Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025
Efficiency
Inventory Average 0.68M0.55M0.93M0.87M0.88M0.86M0.85M0.93M0.82M0.58M0.51M0.64M0.83M0.85M0.79M
Assets Average 20.26M22.37M22.87M29.30M28.61M28.11M27.86M25.87M22.07M18.86M27.06M26.33M24.01M
Equity Average 3.62M7.53M11.26M10.41M13.96M17.24M14.88M15.11M15.66M14.79M9.88M9.50M14.48M15.24M17.84M
Invested Capital 3.29M4.17M11.15M13.24M9.44M18.52M28.11M15.91M17.55M16.10M14.79M5.18M14.05M15.15M15.54M20.31M
Leverage & Solvency
Debt to Equity 0.050.230.170.710.000.760.150.000.080.020.100.040.500.050.01
Debt Ratio 0.140.080.310.000.350.090.000.050.010.030.030.240.040.00
Equity Ratio 0.640.500.430.770.460.610.490.670.500.350.600.490.710.77
Valuation
Enterprise Value -0.76M-0.76M143.97M19.24M5.43M34.51M15.16M2.63M-10.89M-14.01M-15.04M-15.96M-9.70M-10.46M-8.38M3.45M
Market Capitalization 153.42M28.61M12.72M41.79M28.55M15.99M4.72M1.56M2.33M1.41M2.37M1.62M9.75M21.61M